Long-Term Exposure to Oroxylin A Inhibits Metastasis by Suppressing CCL2 in Oral Squamous Cell Carcinoma Cells

Wei-Ting Ku1, Jiun-Jia Tung2,3, Tony Jer-Fu Lee4,5

  • 1Master Program of Pharmacology and Toxicology, Department of Medicine, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan. 106721104@gms.tcu.edu.tw.

Cancers
|March 16, 2019
PubMed

Insights

Oroxylin A (Oro-A) significantly inhibits oral squamous cell carcinoma (OSCC) migration and metastasis. Long-term Oro-A treatment suppresses cancer cell migration by downregulating CCL2 signaling pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Oroxylin A (Oro-A), a flavonoid from Scutellaria radix, shows anti-migration effects in cancer.
  • Oral squamous cell carcinoma (OSCC) is a significant global health concern with migratory potential.

Purpose of the Study:

  • To investigate the anti-migration effects of Oro-A on OSCC cells.
  • To elucidate the molecular mechanisms behind Oro-A's anti-migratory action in OSCC.

Main Methods:

  • Wound-healing assays for cell migration assessment.
  • cDNA microarray and Ingenuity software for gene expression analysis.
  • Quantitative real-time PCR (Q-PCR), Western blotting, and ELISA for validating gene and protein expression (CCL2, p-ERK1/2, NFκB, MMP2, MMP9).

Main Results:

  • Short-term and long-term Oro-A exposure significantly inhibited OSCC cell migration.
  • Long-term Oro-A treatment led to significant downregulation of migration-related genes, including CCL2.
  • Oro-A suppressed CCL2 signaling pathway components and downstream targets, inhibiting in vivo metastasis.

Conclusions:

  • Long-term Oroxylin A treatment effectively inhibits OSCC cell migration and metastasis.
  • The anti-metastatic effect of Oro-A is mediated through the downregulation of the CCL2 signaling pathway.
  • Oro-A demonstrates potential as a therapeutic agent for OSCC treatment.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
Oral Cavity01:11

Oral Cavity

The oral cavity, or the mouth, is a complex structure in humans that plays a vital role in our day-to-day lives. Its role is not only in chewing and swallowing food; it also plays a role in speech and facial expressions.
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
3.1K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K